New Experimental COVID-19 Pill “Molnupiravir” Reduces Hospitalizations, Deaths By Half; Same Manufacturer of “Ivermectin”

posted in: All news, News | 0

KENILWORTH, NJ – On Friday, multinational pharmaceutical company Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that an experimental COVID-19 pill they are working on has cut the number of study cases leading to hospitalization or death by half, and that they have plans to submit the new medication to the Food […]